Gillian Cannon
Director/Board Member at CORCEPT THERAPEUTICS INCORPORATED
Net worth: - $ as of 2024-03-30
Profile
Gillian M.
Cannon is currently serving as an Independent Director at Corcept Therapeutics, Inc., Director at Affibody AB, Director at Xenon Pharmaceuticals, Inc., Director at Edinburgh Innovations Ltd., and Head-Commercial Innovation at Roivant Sciences, Inc. She is also the President of Alyvant, Inc. Dr. Cannon has previously worked as the President-North American Operations at UCB, Inc. and Vice President-Commercial Operations at Merck BioVentures.
She has an undergraduate degree from The University of Edinburgh and doctorate degrees from Temple University (Pennsylvania) and Fox School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-08-09 | 0 ( -.--% ) | - $ | 2024-03-30 | |
| 2024-04-04 | 0 ( -.--% ) | - $ | 2024-03-30 |
Gillian Cannon active positions
| Companies | Position | Start |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Director/Board Member | 2020-11-22 |
| XENON PHARMACEUTICALS INC. | Director/Board Member | 2023-08-07 |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Director/Board Member | 2018-12-31 |
| Alyvant, Inc. | President | 2017-12-31 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 2020-03-31 |
Edinburgh Innovations Ltd.
 Edinburgh Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Edinburgh Innovations Ltd. engages in the provision of management service for the University of Edinburgh. The company is headquartered in Edinburgh, the United Kingdom. | Director/Board Member | 2019-12-31 |
Former positions of Gillian Cannon
| Companies | Position | End |
|---|---|---|
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Corporate Officer/Principal | 2016-12-31 |
| Merck BioVentures | Corporate Officer/Principal | 2011-12-31 |
Training of Gillian Cannon
| The University of Edinburgh | Undergraduate Degree |
| Temple University (Pennsylvania) | Doctorate Degree |
| Fox School of Business | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| Private companies | 6 |
|---|---|
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Finance |
Edinburgh Innovations Ltd.
Edinburgh Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Edinburgh Innovations Ltd. engages in the provision of management service for the University of Edinburgh. The company is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
| Merck BioVentures | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
| Alyvant, Inc. |
- Stock Market
- Insiders
- Gillian Cannon
